2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
7
Thyroid Nodule
4
Neoplasms
4
Liver Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcopenia
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Mouth Neoplasms
3
Liver Cirrhosis
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Postoperative Complications
2
Ovarian Cysts
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hypersensitivity
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Interventions
Temozolomide
159
Bevacizumab
69
Radiotherapy
68
Magnetic Resonance Spectroscopy
68
Irinotecan
31
Surgical Procedures, Operative
27
Radiation
24
Carboplatin
23
Specimen Handling
20
Carmustine
20
Blood Specimen Collection
20
Nivolumab
19
Aminolevulinic Acid
18
Biopsy
17
Lomustine
15
pembrolizumab
13
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
trametinib
12
fluorodopa F 18
12
X-Rays
12
Radiosurgery
12
Erlotinib Hydrochloride
12
Topotecan
11
Everolimus
11
Magnetic Resonance Imaging
10
IL13-PE38
10
dabrafenib
9
Etoposide
9
Drug Therapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Ultrasonography
×
Clear all
NCT05062772
2024-11-15
BraTioUS-DB
Hospital del Rio Hortega
Completed
150 enrolled